ArticleHerz2012
Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients.
Article in Herz, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.
- Is pulmonary hypertension protective against cardiac tamponade? A systematic review.Internal and emergency medicine · 2024Pooled it
- Guideline
- Diagnostic Yield of Routine Pericardial Fluid Cultures and Clinical Predictors of Bacterial Pericarditis.Diagnostics (Basel, Switzerland) · 2026Article
- Diagnostic value of FDG PET/CT in determining the etiology of pericardial effusion.Annals of nuclear medicine · 2025Article
- Surgical Management Strategies for Pericardial Effusion-A Systematic Review.Journal of clinical medicine · 2025Review
- Double Trouble in the Pericardium: A Rare Co-Infection of Tuberculosis and Tularemia Leading to Cardiac Tamponade.Journal of medical cases · 2025Article
- Article
- Incidence of secondary pericardial effusions associated with different etiologies: a comprehensive review of literature.Journal of cardiothoracic surgery · 2025Review
- Safety and Efficacy of Echo- vs. Fluoroscopy-Guided Pericardiocentesis in Cardiac Tamponade.Medicina (Kaunas, Lithuania) · 2025Observational
- An infusion port for recurrent massive pericardial effusion: a case report.European heart journal. Case reports · 2024Article
- Article
- Epidemiological characteristics, etiological spectrum, and outcomes of adult patients with pericardial effusion at a Teaching Hospital in Somalia.Therapeutic advances in chronic disease · 2024Article
- Pericardial Effusion and Cardiac Tamponade Pathophysiology and New Approaches to Treatment.Current cardiology reports · 2023Review
- Precautions When Performing Pericardiocentesis in Patients with Cardiac Tamponade-complicated Malignancy: A Case Report and Review of the Literature.Internal medicine (Tokyo, Japan) · 2023Review
- Incidence of malignant pericardial effusion in pericardiocentesis patients and post-procedure care: an oncology center pilot study.American journal of translational research · 2023Article
- Article
- Unveiling the causes of pericardial effusion in a contemporary case series of pericardiocentesis in Latin America.Scientific reports · 2022Article
- Automated Detection, Segmentation, and Classification of Pericardial Effusions on Chest CT Using a Deep Convolutional Neural Network.Diagnostics (Basel, Switzerland) · 2022Article
- The safety of pericardiocentesis in patients under antithrombotic therapy: A single-center experience.Frontiers in cardiovascular medicine · 2022Article
- Characteristics and Clinical Outcomes of Cancer Patients who Developed Constrictive Physiology After Pericardiocentesis.Korean circulation journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCauses of pericardial effusion requiring pericardiocentesis are very complex; a summary of 140 patients, especially those having iatrogenic pericardial effusion, is rare.
methodsWe prospectively analyzed the clinical data and etiology of moderate to large pericardial effusion requiring pericardiocentesis and drainage in 140 consecutive Han Chinese patients from January 2007 to December 2009.
resultsPericardiocentesis was successfully performed and effective in all patients. There were 9 cases with transudates, while the remaining 131 cases were diagnosed with exudates (neoplastic in 54 patients, tuberculous in 40 patients, 9 cases of connective tissue diseases, 12 cases undergoing cardiac catheterization, and 8 cases of acute myocardial infarction). Among the 54 malignancies, 30 patients had lung cancer, 7 had breast cancer, and 4 had liver cancer. No differences in the clinical characteristics and the results of routine and biochemistry studies in the pericardial fluid between tuberculous and malignant groups were found. Of the 12 patients undergoing cardiac catheterization, 6 cases had undergone catheter ablation for tachycardia and 4 cases had undergone percutaneous coronary intervention. The 6 patients undergoing catheter ablation were women and the ratio of pericardial effusion was higher in women (6/436) than in men (0/462; p<0.05). Pericardiocentesis and drainage was effective in the 6 patients who underwent catheter ablation, and the remaining 6 patients underwent surgical intervention after pericardiocentesis and drainage. All 8 patients with acute myocardial infarction died during hospitalization.
conclusionIn China, most moderate to large pericardial effusions requiring pericardiocentesis and drainage were exudates and bloody, which were mainly caused by malignancy and tuberculosis. However, the incidence of iatrogenic pericardial effusion has been increasing and should not be ignored. Pericardiocentesis and drainage were effective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.